Predator-Prey in Tumor-Immune Interactions: A Wrong Model or Just an Incomplete One?Irina Kareva(Tufts Children's Hospital), Joel S. Brown(Moffitt Cancer Center)Frontiers in ImmunologyAugust 31, 202110.3389/fimmu.2021.668221Cited by 50SaveCiteExport RISWatch citationsRelated PapersMetronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance|Cancer Letters|2014|254